CHMX · As filed with the SEC
NEXT-ChemX cash flow statement, by quarter
The statement as NEXT-ChemX presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Condensed Statements of Cash Flows (Unaudited) · USD
| USD | Q2 2025† 3 months ended Jun 30, 2025 | Q1 2025 3 months ended Mar 31, 2025 | Q4 2024† 3 months ended Dec 31, 2024 | Q3 2024† 3 months ended Sep 30, 2024 | Q2 2024† 3 months ended Jun 30, 2024 | Q1 2024 3 months ended Mar 31, 2024 | Q4 2023† 3 months ended Dec 31, 2023 | Q3 2023† 3 months ended Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net income (loss) | (455,639)† | (465,926) | (594,935)† | (279,604)† | (308,488)† | (518,963) | (582,677)† | (922,858)† |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Depreciation and amortization | 38,691† | 38,780 | 151,116† | (73,557)† | (36,112)† | 1,334 | 1,334† | 1,334† |
| Other income received in 3rd party stock | — | — | — | — | — | — | 0† | 0† |
| Unrealized loss on trading securities | — | — | — | — | — | 19,987 | — | — |
| Consultant commission paid in third party stock | — | — | — | — | — | — | 0† | 0† |
| Unrealized gain on trading securities | 6,275† | (8,699) | 29,680† | 17,331† | (40,603)† | — | — | — |
| Changes in Operating Assets and Liabilities: | ||||||||
| Net Cash from Operating Activities | (11,800)† | 31,570 | 3,000† | 28,040† | 24,000† | 20,207 | — | — |
| Prepaid expenses | — | (12,635) | (13,298)† | (60,448)† | (453,519)† | (4,178) | 4† | 324† |
| Accounts payable and accrued liabilities | 111,940† | 209,975 | (75,426)† | 196,931† | 245,645† | 188,925 | 334,088† | 224,411† |
| Net cash provided by (used in) operating activities | (328,571)† | (206,935) | (499,863)† | (171,307)† | (569,077)† | (292,688) | (178,432)† | (196,789)† |
| FINANCING ACTIVITIES | ||||||||
| Stock Repurchases (Issuances) | — | — | — | — | — | — | 0† | 0† |
| Proceeds from Debt Issuance | 350,000† | 145,000 | — | — | 475,000† | — | — | — |
| Proceeds from Debt Issuance | — | 0 | 0† | 0† | 0† | 20,000 | — | — |
| Proceeds from Debt Issuance | — | — | 539,004† | 206,000† | 475,000† | 365,000 | — | 270,000† |
| Repayment of notes payable | — | — | — | — | — | — | 20,000† | (70,000)† |
| Net cash provided by (used in) financing activities | 350,000† | 145,000 | 527,024† | 206,000† | 475,000† | 385,000 | 120,000† | 200,000† |
| Net increase (decrease) in cash | 21,429† | (61,935) | 27,161† | 34,693† | (94,077)† | 92,312 | (58,432)† | 3,211† |
| Cash, beginning of year | 612 | 62,547 | 35,386 | 693 | 94,770 | 2,458 | 60,890 | 57,679 |
| Cash, end of the period | 22,041 | 612 | 62,457 | 35,386 | 693 | 94,770 | 2,458 | 60,890 |
| SUPPLEMENTAL DISCLOSURES | ||||||||
| Interest Expense | — | — | — | — | — | — | 0† | — |
| NON-CASH INVESTING AND FINANCING ACTIVITIES | ||||||||
| Conversion of loan, interest and debt to convertible note | — | — | — | 0† | — | — | — | — |
| Issuance of Preferred Stocks against Indebtedness | — | — | 0† | 20† | — | — | — | — |
† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.